Drugs
Drugs
Drugs
GENERIC NAME: HIV infection, A synthetic Adverse reactions pertain to Alert: Stop treatment immediately and notify Inform patient that long-term effects
Epivir, Epivir-HBV with other nucleoside the combination therapy of prescriber if signs, symptoms, or laboratory of drug aren't known.
antiretrovirals analogue that lamivudine and zidovudine. abnormalities suggest pancreatitis. Monitor Stress importance of taking drug
BRAND NAME: Chronic hepatitis inhibits HIV and CNS: headache, fatigue, amylase level. exactly as prescribed.
lamivudine B with evidence HBV reverse fever, neuropathy, malaise, Alert: Lactic acidosis and hepatotoxicity have Inform patient that drug doesn't cure
of hepatitis B transcription via dizziness, insomnia and been reported. Notify prescriber if signs of HIV infection, that opportunistic
CLASSIFICATION: virus (HBV) viral DNA chain other sleep disorders, lactic acidosis or hepatotoxicity occurs. infections and other complications of
antiretroviral replication and termination. RNA- depressive disorders. Hepatitis may recur in some patients with HIV infection may still occur, and that
active liver and DNA- EENT: nasal symptoms. chronic HBV when they stop taking drug. transmission of HIV to others through
DOSAGE: inflammation dependent DNA GI: nausea, diarrhea, Safety and effectiveness of Epivir-HBV for sexual contact or blood contamination
Epivir polymerase vomiting, anorexia, longer than 1 year haven't been established; is still possible.
Oral solution: 10 activities. abdominal pain, abdominal optimum duration of treatment isn't known. Teach parents or guardians the signs
mg/ml cramps, dyspepsia, Test patients for HIV before starting and symptoms of pancreatitis. Advise
Tablets: 150 mg, 300 pancreatitis. treatment and during therapy because form them to report signs and symptoms
mg Hematologic: neutropenia, and dosage of lamivudine in Epivir-HBV aren't immediately.
anemia, appropriate for those infected with both HBV
Epivir-HBV thrombocytopenia. and HIV. If lamivudine is given to patients
Oral solution: 5 Hepatic: hepatotoxicity. with HBV and HIV, use the higher dosage
mg/ml Metabolic: lactic acidosis. indicated for HIV therapy as part of an
Tablets: 100 mg Musculoskeletal: appropriate combination regimen.
musculoskeletal pain, Because of a high rate of early virologic
myalgia, arthralgia. resistance, don't use triple antiretroviral
Respiratory: cough. therapy with abacavir or didanosine,
Skin: rash. lamivudine, and tenofovir as new treatment
Other: chills. for never-treated or pretreated patients.
Monitor patients currently taking this therapy
and those who take it with other
antiretrovirals, and consider a different
therapy..
Monitor patient's CBC, platelet count, and renal
and liver function studies. Report
abnormalities.